Introduction {#Sec1}
============

Within head and neck cancer (HNC) research and clinical management, greater importance is now being placed on understanding the sequelae impacting patients post cancer treatment. Such information is essential to guide rehabilitation and optimise patient function, psychological health and quality of life for improved survivorship care following cancer. Within the subgroup of patients who present with laryngeal cancer managed with organ-preservation treatments, the negative impacts of (chemo)radiotherapy \[(C)RT\] treatment on function, health-related quality of life (HRQL) and psychological well-being/distress have been investigated to varied extents.

Regarding impact to voice function and communication after laryngeal cancer treatment, research indicates that patients will experience vocal function changes that vary from mild to severe in nature. Often presenting as a complex dysphonia, the voice post (C)RT has been characterised as harsh, rough, strained and breathy, with glottal fry and altered pitch which may remain with the patient long term \[[@CR1]--[@CR5]\]. Patients themselves report poor vocal quality, hoarseness, reduced volume and vocal fatigue following laryngeal cancer treatment \[[@CR6]--[@CR9]\].

Many studies have also investigated (HRQL) and global quality of life (QOL) outcomes post laryngeal cancer. Research specific to non-surgical treatment outcomes indicates that the majority of HRQL (function and symptom scales) deteriorate 1 month post radiotherapy then improve 6--12 months to reach baseline levels (pre-radiotherapy), although these remain below normative values \[[@CR1], [@CR10]\]. Most HRQL function and symptom outcomes present at 12 months continue to persist long term, up to 5 years post radiotherapy \[[@CR11]\].

However, whilst the impact on functional outcomes and quality of life has been well explored, research into patient *psychological well-being*/*distress* post laryngeal cancer has been examined to a lesser extent. Studies suggest that up to 41% of patients experience possible/probable anxiety or depression \[[@CR12]\] which may be most prevalent either pre-radiotherapy \[[@CR10]\] or 12 months post \[[@CR13]\] and continues to persist years after management \[[@CR14]\]. Johansson and colleagues (2011) also identified that patients' mental adjustment to laryngeal cancer and their coping strategies significantly impact anxiety, depression, HRQL and survival \[[@CR15]\].

Given the extent of functional impairments and reduced quality of life outcomes after laryngeal cancer treatment, recent research has explored potential benefits of behavioural voice rehabilitation for this clinical group. Studies indicate that voice rehabilitation post laryngeal cancer significantly improves voice (acoustic and perceptual qualities), patient perceptions, communication and several HRQL outcomes when compared to a laryngeal cancer cohort who did not receive voice rehabilitation \[[@CR9], [@CR16]--[@CR19]\]. Furthermore, there is a known interrelationship between function, quality of life and patient well-being. Rinkel and colleagues (2014) highlighted that, specifically within the laryngeal cancer population, the prevalence of voice, communication (and swallowing) problems after laryngeal cancer treatment is high and clearly related to quality of life and emotional distress \[[@CR20]\]. Consequently, it could be hypothesised that patients who receive rehabilitation for their voice deficits following laryngeal cancer, and experience positive functional and HRQL effects, may also experience positive benefits for their psychological well-being.

However, whilst results from rehabilitation trials have demonstrated improved voice function and positive impacts to HRQL outcomes, to date, any potential impact on psychological well-being has not been examined. Given the interrelationship between function, HRQL and psychological well-being, this study aims to determine if there is also an associated effect on patient well-being/distress, specifically experiences of anxiety and/or depression for patients who receive behavioural voice intervention following (chemo)radiotherapy for laryngeal cancer.

Methodology {#Sec2}
===========

Study population {#Sec3}
----------------

The current data were collected as part of a larger, prospective randomised control trial at Sahlgrenska University Hospital, Gothenburg, Sweden \[[@CR18], [@CR19]\]. Ethical approval was granted and the study was conducted in accordance with the Declaration of Helsinki. Patients diagnosed with laryngeal cancer (Tis-T4) in the Västra Götaland Region were referred to a weekly tumour conference at the Otorhinolaryngology Department and invited to be part of the study. Inclusion criteria for the study were laryngeal cancer patients planned for curative (chemo)radiotherapy, who had sufficient Swedish language competency to independently answer questionnaires and partake in voice rehabilitation. Exclusion criteria were tracheostomy and severe cognitive impairment limiting participation in voice rehabilitative exercises. A total of 163 patients were available for inclusion, of which 89 agreed to participate or remained eligible for study participation (CONSORT flow diagram, Fig. [1](#Fig1){ref-type="fig"}). Randomisation occurred electronically using Pocock's sequential randomisation method \[[@CR21]\] considering patient's age, smoking status, tumour site, size and self-evaluation of communication pre (C)RT. Twenty-six patients were lost to follow-up, leaving a total of 63 patients available for analyses. Comparisons of the demographics between the two groups confirmed there were no significant differences between the voice rehabilitation (VR) and control groups when compared for gender, mean age, tumour location, radiotherapy regime, comorbidity or working status (Table [1](#Tab1){ref-type="table"}).Fig. 1Consolidated Standards of Reporting Trials (CONSORT) flow diagram Table 1Patient inclusion demographicsControl group *n* (%)Voice rehabilitation *n* (%)Difference *p* valuePatients3231 Gender0.96  Male28 (87)27 (87)  Female4 (13)4 (13) Mean age (years)62.165.80.19 Range41--8241--86Tumour location0.59 Glottic (78%)24 (75)25 (81)  Tis10  T11519  T276  T310 Supraglottic (22%)8 (25)6 (19)  T112  T232  T341  T401Radiotherapy0.46 Conventional23 (72)19 (61) Hyperfractionated9 (28)12 (39)Comorbidity (ACE-27)^a^(*n* = 31)^b^0.22 None13 = (42)13 = (42) Mild14 = (45)9 = (29) Moderate4 = (13)9 = (29) Severe00Working status---employed14 (44)12 (39)0.69Vocally demanding work^c^7/14 (50)7/12 (58)0.95^a^Adult Comorbidity Evaluation (ACE-27) \[[@CR35]\]^b^One patient with missing data^c^As determined by patient report

Oncologic treatment {#Sec4}
-------------------

The radiotherapy regime, as determined by regional guidelines, was either (1) conventional, once daily radiotherapy at 2--2.4 Gy fractions to a total of 62.4--68 Gy, or (2) hyperfractionated, twice daily radiotherapy at 1.7 Gy fractions to a total of 64.6 Gy. Patients with T2--T4 tumours generally received radiation to lymph nodes (*n* = 24) and three patients with T3--T4 tumours also received induction chemotherapy.

Procedure {#Sec5}
---------

Outcome assessments occurred at baseline, i.e., 1 month post (chemo)radiotherapy cessation (pre-voice rehabilitation), and post voice rehabilitation at 6 and at 12 months post (C)RT. At each time point, all patients completed an assessment battery including voice recording and analyses, self-reported communication experiences and health-related quality of life measures. These results have been previously reported \[[@CR9], [@CR18], [@CR19]\]. For the current study, only the data relating to patient perceptions of their voice acceptability and the data relating to patient well-being, as reported by the Hospital Anxiety and Depression Scale \[[@CR22]\], is examined. The Hospital Anxiety and Depression Scale (HADS) was developed for the general medical patient population and has been used extensively both clinically and within research \[[@CR23]\]. It consists of the two scales, anxiety and depression, each with seven questions answered on a 0--3 scale, where a larger number represents greater symptoms of anxiety/depression. Within each scale, summated scores of \<8 indicate no case of anxiety/depression, scores of 8--10 indicate possible anxiety/depression and scores ≥11 indicate probable anxiety/depression \[[@CR22]\]. Patient's voice perceptions were examined using a study-specific questionnaire, reported in earlier studies \[[@CR9], [@CR24], [@CR25]\]. However, from this, only the question examining whether the patient believed their voice to be acceptable in a social environment, answered on a Likert scale with 0 = never, 1 = sometimes, 2 = often and 3 = always, was included in this study.

Voice rehabilitation occurred between pre-voice rehabilitation (1 month post treatment) and the 6-month post (C)RT time point. Voice rehabilitation consisted of 10 speech pathology intervention sessions over 10 weeks using a structured protocol consisting of both direct and indirect voice intervention, including tasks such as breathing, relaxing, posture and specific physiology-targeted phonation exercises \[[@CR9]\]. The final sessions focused on transferability of skills and generalisation into conversation and holistic communication. The control group received general voice education such as vocal hygiene advice, but not specific intervention.

Statistical methods {#Sec6}
-------------------

Descriptive statistics were used to calculate the proportion of HADS 'no case' versus 'possible/probable' anxiety and depression. Within- and between-group statistical analyses were conducted using SPSS statistics software, version 22, with a significance set at *p* \< 0.05. Within-group analysis (across time points) was calculated using the McNemar chi-square test for categorical data. Difference between groups was calculated using the chi-square statistic. Correlation between possible/probable anxiety or depression (dichotomous variable) and patient voice perceptions (ordinal data) was calculated using point-biserial correlation coefficient (*r* ~pb~) using VassarStats: Website for Statistical Computation \[[@CR26]\]. Correlation strength was interpreted using the following criteria: 0.00--0.30 = negligible correlation, 0.30--0.50 = low correlation, 0.50--0.70 = moderate correlation, 0.70--0.90 = high correlation and 0.90--1.00 = very high correlation \[[@CR27]\].

Results {#Sec7}
=======

Within- and between-group comparisons are displayed in Table [2](#Tab2){ref-type="table"}. Within-group analysis showed a trend (*p* = 0.06), in the VR group, towards a reduction in number of possible/probable *anxiety* cases at 6 months, and by 12 months, the number of possible/probable *anxiety* cases was significantly lower (*p* = 0.03) than pre-voice rehabilitation. No significant change in cases of *depression*, in the VR group, was observed over time. For the control group, no changes were observed in the proportion of patients reporting anxiety or depression across any of the time points.Table 2Between- and within-group analysis of the proportion of patients with no, possible or probable anxiety and depression at each time pointPre-VR number (%)6 months number (%)12 months number (%)Within-group analysisPre-VR to 6 months *p* value6 to 12 months *p* valuePre-VR to 12 months *p* valueControl group Anxiety  No case21 (66)23 (72)24 (75)0.731.000.38  Possible/probable11 (34)9 (28)8 (25) Depression  No case20 (63)25 (78)24 (75)0.181.000.22  Possible/probable12 (37)7 (22)8 (25)VR group Anxiety  No case23 (74)28 (90)29 (94)0.061.00*0.03*  Possible/probable8 (26)3 (10)2 (6) Depression  No case25 (81)29 (94)29 (94)0.291.000.22  Possible/probable6 (19)2 (6)2 (6)Between-group analysis Anxiety*p =* 0.50*p =* 0.06*p = 0.04* Depression*p =* 0.11*p =* 0.08*p = 0.04*Statistical significance (*p* \< 0.05) indicated by italic font*VR* voice rehabilitation

Between-group analyses revealed no significant difference between groups at baseline; however, at 6 months, the VR group reported less cases of possible/probable anxiety and depression, a difference approaching significance (*p =* 0.06 and *p* = 0.08, respectively). By 12 months, however, the two groups were statistically significantly different (*p* = 0.04) with the VR group reporting significantly less cases of anxiety and depression than the controls. Within the VR group at 12 months, significant correlations were found between positive patient perceptions of voice acceptability and the reduction in cases of anxiety (*p* = 0.03, *r* ~pb~ = −0.38) and depression (*p* \< 0.001, *r* ~pb~ = −0.66).

Discussion {#Sec8}
==========

Results from the current study suggest associated positive effects on psychological well-being following voice rehabilitation. At baseline (post radiotherapy/pre-voice rehabilitation), both the control and VR groups were statistically similar in their reported cases of anxiety/depression, and results from this study are largely comparable to prior research which indicates that 15 and 23% of patients report anxiety and depression (respectively), immediately post radiotherapy \[[@CR13]\]. Following voice rehabilitation, our results demonstrate that there was a continued reduction in the proportion of patients with anxiety between baseline---6 months---and between 6 and 12 months within the VR group only. By 12 months, the proportion of anxiety (6%) and depression (6%) cases in the VR group were significantly lower than the control group where 25% continued to report ongoing anxiety or depression. The control group data in the current study is largely comparable to previous literature. Hammerlid et al. (1998) found 26 and 24% of their patients indicated anxiety and depression (respectively) at 12 months \[[@CR13]\] whilst, similarly, results from a cross sectional study reported that 32 and 25% of patients reported anxiety and depression (respectively) post laryngeal cancer treatment \[[@CR12]\]. Johansson et al. (2008), however, presented comparatively lower anxiety and depression figures at 12 months \[[@CR10]\]. These data from previous studies are generally congruent with this study's control group's proportions of anxiety and depression and further support the observations that our VR group presents with lower cases of anxiety and depression than typically reported for this population, 12 months post (C)RT.

A number of possible theories could be proposed for why there were improved cases of anxiety and depression following voice rehabilitation. One possible reason could be the improved functional outcomes achieved by voice rehabilitation. Prior studies have reported positive voice function (acoustic and perceptual) outcomes following voice rehabilitation compared to no voice rehabilitation \[[@CR9], [@CR16]\]. Furthermore, Karlsson and colleagues (2015) demonstrated that voice rehabilitation significantly improved communication, social function, social contact and quality of life at 6 months post rehabilitation when compared to a control group \[[@CR19]\]. Indeed, in the current study, positive perceptions of voice acceptability were significantly correlated with fewer cases of anxiety and depression. This interrelationship and impact of function on quality of life and psychological well-being/distress is not a new phenomenon and has been reported both in the laryngeal cancer population \[[@CR20]\] in the larger HNC population \[[@CR28], [@CR29]\].

However, it should be noted that the correlations between voice acceptability (the patient perceptions of voice function) and anxiety/depression were small to moderate in size. As such, additional factors contributing to the positive benefits observed for the VR group, such as broader impacts of behavioural intervention, should be considered. Within HNC trials, it has been observed that those trials which focus on improving function, as well as effective communication, problem-solving, and distress, result in reduced social impairment, psychological distress and improved HRQL \[[@CR30]\]. Given that our study's intervention arm focused on improving voice function, facilitating effective communication and transferring skills into the patient specific communication/social environment, it is possible that an improvement in these functional skills positively affected quality of life and patient well-being outcomes, secondary to the interrelation between these parameters.

The current data raises some important clinical implications. Function rehabilitation post laryngeal cancer treatment has shown to improve communication and HRQL outcomes \[[@CR9], [@CR16], [@CR18], [@CR19]\] and, now, the current data supports potential positive benefits for patient well-being/distress. Furthermore, it is recognised more broadly in the literature that survivorship care should incorporate both function rehabilitation and psychosocial intervention \[[@CR28], [@CR31]--[@CR33]\]. Recent research within HNC literature, investigating behavioural and psychosocial intervention post treatment, suggests that structured, theoretically based interventions which address functional, HRQL and psychosocial impairments and incorporate problem-focused, self-management, collaborative goal-setting, action-planning, shared care and linkage to health-care supports are key elements for survivorship care \[[@CR31]--[@CR33]\]. Although the current voice rehabilitation program used in this RCT was not developed with this specific focus, it has achieved some of these desired benefits. Future development of behavioural interventions for the laryngeal cancer population need to ensure that rehabilitation is sufficiently holistic to support the patient in their recovery, focusing on both function rehabilitation and psychosocial management.

Limitations of this study include the heterogeneous laryngeal cancer cohort used within this study, including both glottic and supraglottic tumours and stage I--stage IV cancers. However, the focus on voice rehabilitation within the laryngeal cancer population specifically versus the larger HNC population is also considered to be a strength of this study. Furthermore, our study's cohort is reflective of the usual laryngeal cancer demographics \[[@CR34]\]; therefore, results from this study may be generalisable to the larger laryngeal cancer patient population. It is acknowledged that no data on patient coping skills, adjustment, or other reasons for the observed levels of anxiety or depression were examined. As such, it is possible that other factors, unrelated to the voice rehabilitation, could account for the current findings. Investigation and incorporation of these factors are recommended for future trials.

Conclusion {#Sec9}
==========

Although voice rehabilitation has shown to improve functional outcomes and positively impact HRQL, the current data suggests positive associated effects of behavioural voice intervention on psychological distress/well-being. This study found lower rates of possible/probable anxiety and depression being reported at 6 and 12 months in the VR group compared to controls, and this improvement in anxiety/depression correlated moderately with patient perceptions of voice acceptability. Results highlight potential additional benefits of behavioural voice intervention beyond achieving direct change to voice function.
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